These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 14657819

  • 1. Benefit and risk of heparin for maintaining peripheral venous catheters in neonates: a placebo-controlled trial.
    Klenner AF, Fusch C, Rakow A, Kadow I, Beyersdorff E, Eichler P, Wander K, Lietz T, Greinacher A.
    J Pediatr; 2003 Dec; 143(6):741-5. PubMed ID: 14657819
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The efficacy of heparinization in prolonging patency of arterial and central venous catheters in children: a randomized double-blind trial.
    de Neef M, Heijboer H, van Woensel JB, de Haan RJ.
    Pediatr Hematol Oncol; 2002 Dec; 19(8):553-60. PubMed ID: 12487830
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Heparin-induced thrombocytopenia in left ventricular assist device bridge-to-transplant patients.
    Schroder JN, Daneshmand MA, Villamizar NR, Petersen RP, Blue LJ, Welsby IJ, Lodge AJ, Ortel TL, Rogers JG, Milano CA.
    Ann Thorac Surg; 2007 Sep; 84(3):841-5; discussion 845-6. PubMed ID: 17720387
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Heparin-induced thrombocytopenia following cardiac surgery is associated with poor outcome.
    Kuitunen A, Suojaranta-Ylinen R, Raivio P, Kukkonen S, Lassila R.
    J Cardiothorac Vasc Anesth; 2007 Feb; 21(1):18-22. PubMed ID: 17289474
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia.
    Juhl D, Eichler P, Lubenow N, Strobel U, Wessel A, Greinacher A.
    Eur J Haematol; 2006 May; 76(5):420-6. PubMed ID: 16466367
    [Abstract] [Full Text] [Related]

  • 11. Outcome of postoperative critically ill patients with heparin-induced thrombocytopenia: an observational retrospective case-control study.
    Gettings EM, Brush KA, Van Cott EM, Hurford WE.
    Crit Care; 2006 May; 10(6):R161. PubMed ID: 17109753
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Preoperative detection and management of immune heparin-induced thrombocytopenia in patients undergoing heart surgery with iloprost.
    Palatianos GM, Foroulis CN, Vassili MI, Matsouka P, Astras GM, Kantidakis GH, Iliopoulou E, Melissari EN.
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):548-54. PubMed ID: 14762367
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Heparin-induced thrombocytopenia: clinical manifestations and management strategies.
    Menajovsky LB.
    Am J Med; 2005 Aug; 118 Suppl 8A():21S-30S. PubMed ID: 16125511
    [Abstract] [Full Text] [Related]

  • 16. The incidence and implications of anti-heparin-platelet factor 4 antibody formation in a pediatric cardiac surgical population.
    Mullen MP, Wessel DL, Thomas KC, Gauvreau K, Neufeld EJ, McGowan FX, Dinardo JA.
    Anesth Analg; 2008 Aug; 107(2):371-8. PubMed ID: 18633010
    [Abstract] [Full Text] [Related]

  • 17. Prevalence of heparin-induced thrombocytopenia in patients undergoing cardiac catheterization.
    Foo SY, Everett BM, Yeh RW, Criss D, Laposata M, Van Cott EM, Jang IK.
    Am Heart J; 2006 Aug; 152(2):290.e1-7. PubMed ID: 16875910
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Management of liver transplantation in a patient with a history of heparin-induced thrombocytopenia.
    Fretschner R, Dietrich K, Unertl K, Greinacher A.
    Transpl Int; 2005 Jun; 18(6):664-7. PubMed ID: 15910290
    [Abstract] [Full Text] [Related]

  • 20. P-selectin and antibodies against heparin-platelet factor 4 in patients with venous or arterial diseases after a 7-day heparin treatment.
    Papalambros E, Sigala F, Travlou A, Bastounis E, Mirilas P.
    J Am Coll Surg; 2004 Jul; 199(1):69-77. PubMed ID: 15217633
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.